150 related articles for article (PubMed ID: 3024814)
1. Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.
Lipinski M; Braham K; Philip I; Wiels J; Philip T; Goridis C; Lenoir GM; Tursz T
Cancer Res; 1987 Jan; 47(1):183-7. PubMed ID: 3024814
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies.
Lipinski M; Braham K; Philip I; Wiels J; Philip T; Dellagi K; Goridis C; Lenoir GM; Tursz T
J Cell Biochem; 1986; 31(4):289-96. PubMed ID: 3760036
[TBL] [Abstract][Full Text] [Related]
3. Immunologic characterization of Ewing's sarcoma using mesenchymal and neural markers.
Lizard-Nacol S; Lizard G; Justrabo E; Turc-Carel C
Am J Pathol; 1989 Nov; 135(5):847-55. PubMed ID: 2479272
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of immunology and molecular biology].
Lipinski M; Tursz T
Bull Cancer; 1988; 75(5):417-21. PubMed ID: 3395706
[TBL] [Abstract][Full Text] [Related]
5. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies.
Donner L; Triche TJ; Israel MA; Seeger RC; Reynolds CP
Prog Clin Biol Res; 1985; 175():347-66. PubMed ID: 3991736
[No Abstract] [Full Text] [Related]
6. Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen.
Hamilton G; Fellinger EJ; Schratter I; Fritsch A
Cancer Res; 1988 Nov; 48(21):6127-31. PubMed ID: 2844401
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological characterization of a Ewing's sarcoma case.
Lizard-Nacol S; Mugneret F; Turc-Carel C; Justrabo E
Cancer Detect Prev; 1988; 12(1-6):297-302. PubMed ID: 3180134
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma.
Kontny HU; Lehrnbecher TM; Chanock SJ; Mackall CL
Cancer Res; 1998 Dec; 58(24):5842-9. PubMed ID: 9865744
[TBL] [Abstract][Full Text] [Related]
9. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
11. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
12. [Immunocytologic study of light cell lines established in vitro from Ewing's sarcoma. Identification of neural markers].
Lizard-Nacol S; Justrabo E; Mugneret F; Volk C; Turc-Carel C
C R Seances Soc Biol Fil; 1988; 182(1):118-25. PubMed ID: 2972341
[TBL] [Abstract][Full Text] [Related]
13. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
14. Possible differential diagnosis of neuroblastoma from rhabdomyosarcoma and Ewing's sarcoma by using a panel of monoclonal antibodies.
Sugimoto T; Sawada T; Arakawa S; Matsumura T; Sakamoto I; Takeuchi Y; Reynolds CP; Kemshead JT; Helson L
Jpn J Cancer Res; 1985 Apr; 76(4):301-7. PubMed ID: 3924704
[TBL] [Abstract][Full Text] [Related]
15. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
[TBL] [Abstract][Full Text] [Related]
16. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
[TBL] [Abstract][Full Text] [Related]
17. [Chromosomal translocation (11; 22) in cell lines of Ewing's sarcoma].
Turc-Carel C; Philip I; Berger MP; Philip T; Lenoir G
C R Seances Acad Sci III; 1983; 296(23):1101-3. PubMed ID: 6416622
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols.
Ahmed A; Gilbert-Barness E; Lacson A
Pediatr Dev Pathol; 2004; 7(4):342-7. PubMed ID: 15383930
[TBL] [Abstract][Full Text] [Related]
19. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM
Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
